FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to endocrinology and can be used by doctors of other specialisations. Detected are presence of thyroid gland pathology, disturbance of carbohydrate exchange, heredity in obesity, hypertension and diabetes mellitus, reason of menopause. Value of body weight index is determined and its dynamics in perimenopause period is evaluated. After that prognostic index (PI) is calculated. If PI is higher than zero, higher risk of metabolic syndrome development during nearest five years is predicted, if PI is lower than zero, conclusion about absence of such risk is made.
EFFECT: method allows to realise prediction of risk of metabolic syndrome development in women of 45-55 years depending on thyroid gland state and reason of menopause by totality of informative clinic signs.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING DEVELOPMENT OF OSTEOPENIC SYNDROME IN WOMEN OF PERIMENOPAUSAL AGE | 2009 |
|
RU2408255C2 |
| METHOD OF PREDICTING RISK OF THYROID GLAND DISEASES IN WOMEN OF PERIMENOPAUSAL AGE | 2009 |
|
RU2421127C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING GESTATIONAL DIABETES | 2015 |
|
RU2589663C1 |
| METHOD FOR PREDICTION OF GESTATIONAL DIABETES MELLITUS IN WOMEN PLANNING PREGNANCY | 2023 |
|
RU2816803C1 |
| METHOD FOR PREDICTING OSTEOPENIA AND OSTEOPOROSIS IN WOMEN OF PERIMENOPAUSAL AGE | 2005 |
|
RU2299020C2 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ABDOMINAL OBESITY WITH A STABLE COURSE OF CORONARY HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE II-III CLASS, WHO UNDERWENT MYOCARDIAL REVASCULARIZATION | 2022 |
|
RU2798728C1 |
| METHOD OF SELECTING MEN AT PRE-DIABETES RISK GROUP AND TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2695322C2 |
| METHOD FOR METABOLIC SYNDROME PREDICTION IN THE II TRIMESTER OF PREGNANCY | 2016 |
|
RU2617182C1 |
| DIAGNOSTIC TECHNIQUE FOR METABOLIC SYNDROME IN CHILDREN | 2013 |
|
RU2527847C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER RECEIVING ANTIESTROGENIC THERAPY | 2020 |
|
RU2759233C1 |
